MYELOID NEOPLASM
Clinical trials for MYELOID NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new MYELOID NEOPLASM trials appear
Sign up with your email to follow new studies for MYELOID NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for Hard-to-Treat leukemia
Disease control OngoingThis study is testing a combination of three drugs (azacitidine, venetoclax, and pevonedistat) in adults with a newly diagnosed, aggressive form of acute myeloid leukemia (AML) that is related to prior cancer treatment or other blood disorders. The goal is to find the best dose a…
Matched conditions: MYELOID NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 03:57 UTC
-
New drug cocktail shows promise in Tough-to-Treat leukemia
Disease control OngoingThis large Phase 3 trial tests whether adding two targeted drugs (bortezomib and sorafenib) to standard chemotherapy helps people with newly diagnosed acute myeloid leukemia (AML) live longer without the cancer returning. The study includes over 1,600 participants and focuses on …
Matched conditions: MYELOID NEOPLASM
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 07, 2026 18:41 UTC
-
Promising drug may help kids with rare cancer before transplant
Disease control OngoingThis study tests an investigational drug called CPX-351 in 25 children and young adults (ages 1 to 21) with secondary myeloid neoplasms—cancers that develop after prior cancer treatment. The goal is to see if one or two rounds of CPX-351 can put the cancer into remission before a…
Matched conditions: MYELOID NEOPLASM
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 06, 2026 16:14 UTC